Tekla Healthcare Investors and Tekla Life Sciences Investors

Represented Tekla Healthcare Investors and Tekla Life Sciences Investors, closed-end funds focused on investments in public and private healthcare companies, in connection with their investments in the Series B Preferred financing of Amphivena Therapeutics, Inc., a clinical stage company developing treatments for blood cancers.